Clinical Trial

PCT Guided Antibiotics Use in Critically Ill Adult Patients in China

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 25, 2025 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
Procalcitonin (PCT) has been widely used in the diagnosis and treatment of bacterial infectious diseases in China. The investigators aim to establish an algorithm based on BRAHMS PCT (VIDAS PCT) for patients with severe infections or sepsis in the EICU to reduce antibiotic exposure and verify its validity in the reduction of antibiotic exposure, clinical outcomes and costs saving.
Trial Details
NCT Number NCT06945510
Lead Sponsor China-Japan Friendship Hospital
Conditions Sepsis
Enrollment 800 participants
Start Date 2025-06-30
Primary Completion 2026-06-30 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-04-25